Dioxins: Diagnostic and prognostic challenges arising from complex mechanisms

Journal of Applied Toxicology

Volumn 33, Issue 1, 2013, Pages 1-8

  Rysavy, Noel M ^a   Maaetoft Udsen, Kristina ^a,b   Turner, Helen ^a  

^a CHAMINADE UNIVERSITY OF HONOLULU   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Aryl hydrocarbon receptor; Dioxin; Genomics; TCDD; Toxicology; Yushchenko

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DIOXIN; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN;

CHEMICAL STRUCTURE; CLINICAL FEATURE; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; HUMAN; INTOXICATION; LD 50; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR INTRINSIC ACTIVITY; REVIEW; STRUCTURE ANALYSIS; SYMPTOM;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; DIOXINS; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; GENE EXPRESSION; GENOMICS; HUMANS; LIGANDS; LONGITUDINAL STUDIES; NEOPLASMS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, CELL SURFACE;

ANIMALIA;

EID: 84870387996     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2759     Document Type: Review

References (66)

1. Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S, Hanberg A, Poellinger L. 2002. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc. Natl. Acad. Sci. U.S.A. 99: 9990-9995.
2. Beedanagari SR, Taylor RT, Bui P, Wang F, Nickerson DW, Hankinson O. 2010. Role of Epigenetic Mechanisms in Differential Regulation of the Dioxin-Inducible Human CYP1A1 and CYP1B1 Genes. Mol. Pharmacol. 78: 608-616.
3. Beischlag TV, Luis Morales J, Hollingshead BD, Perdew GH. 2008. The aryl hydrocarbon receptor complex and the control of gene expression. Crit. Rev. Eukaryot. Gene Expr. 18: 207-250.
4. Bertazzi PA, Zocchetti C, Guercilena S, Consonni D, Tironi A, Landi MT, Pesatori AC. 1997. Dioxin exposure and cancer risk: a 15-year mortality study after the "Seveso accident". Epidemiology 8: 646.
5. Casado FL, Singh KP, Gasiewicz TA. 2010. The aryl hydrocarbon receptor: Regulation of hematopoiesis and involvement in the progression of blood diseases. Blood Cells Mol. Dis. 44: 199-206.
6. Cerlesi S, Di Domenico A, Ratti S. 1989. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) persistence in the Seveso (Milan, Italy) soil. Ecotoxicol. Environ. Saf. 18: 149-164.
7. Consonni D, Pesatori AC, Zocchetti C, Sindaco R, D'Oro LC, Rubagotti M, Bertazzi PA. 2008. Mortality in a population exposed to dioxin after the Seveso, Italy, accident in 1976: 25years of follow-up. Am. J. Epidemiol. 167: 847-858.
8. Cypel Y, Kang H. 2010. Mortality Patterns of Army Chemical Corps Veterans Who were Occupationally Exposed to Herbicides in Vietnam. Ann. Epidemiol. 20: 339-346.
9. DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, Perdew GH. 2010a. Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling. Toxicol. Sci. 115: 89-97.
10. DiNatale BC, Schroeder JC, Francey LJ, Kusnadi A, Perdew GH. 2010b. Mechanistic Insights into the Events That Lead to Synergistic Induction of Interleukin 6 Transcription upon Activation of the Aryl Hydrocarbon Receptor and Inflammatory Signaling. J. Biol. Chem. 285: 24388-24397.
11. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SST, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ. 1995. Immune-system impairment and hepatic-fibrosis in mice lacking the dioxin-binding ah receptor. Science 268: 722-726.
12. Geusau A, Abraham K, Geissler K, Sator MO, Stingl G, Tschachler E. 2001. Severe 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Clinical and laboratory effects. Environ. Health Perspect. 109: 865-869.
13. Geyer HJ, Schramm KW, Feicht EA, Behechti A, Steinberg C, Bruggemann R, Poiger H, Henkelmann B, Kettrup A. 2002. Half-lives of tetra-, penta-, hexa-, hepta-, and octachlorodibenzo-p-dioxin in rats, monkeys, and humans - a critical review. Chemosphere 48: 631-644.
14. Hankinson O. 1995. The Aryl Hydrocarbon Receptor Complex. Annu. Rev. Pharmacol. Toxicol. 35: 307-340.
15. Kim Y, Oh S, Kim SH. 2009. Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochem. Biophys. Res. Commun. 379: 324-329.
16. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, Bentz M, Southard J, Bradfield CA. 2000. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 97: 10442-10447.
17. Landi MT, Bergen AW, Baccarelli A, Patterson DG, Grassman J, Ter-Minassian M, Mocarelli P, Caporaso N, Masten SA, Pesatori AC, Pittman GS, Bell DA. 2005. CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from seveso, Italy. Toxicology 207: 191-202.
18. Linden J, Lensu S, Tuomisto J, Pohjanvirta R. 2010. Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance. Front. Neuroendocrinol. 31: 452-478.
19. Long M, Laier P, Vinggaard AM, Andersen HR, Lynggaard J, Bonefeld-Jorgensen EC. 2003. Effects of currently used pesticides in the AhR-CALUX assay: comparison between the human TV101L and the rat H4IIE cell line. Toxicology 194: 77-93.
20. Lorber M, Patterson D, Huwe J, Kahn H. 2009. Evaluation of background exposures of Americans to dioxin-like compounds in the 1990s and the 2000s. Chemosphere 77: 640-651.
21. Maaetoft-Udsen K, Shimoda LMN, Frøkiær H, Turner H. 2012. Aryl hydrocarbon receptor ligand effects in RBL2H3 cells. J Immunotoxicol. Epub ahead of print retrieved May 8, 2012. DOI: 10.3109/1547691X.2012.661802.
22. MacPherson L, Matthews J. 2010. Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor alpha expression in human breast cancer cells. Cancer Lett. 299: 119-129.
23. Mansson M, Phipps RK, Gram L, Munro MH, Larsen TO, Nielsen KF. 2010. Explorative solid-phase extraction (E-SPE) for accelerated microbial natural product discovery, dereplication, and purification. J. Nat. Prod. 73: 1126-1132.
24. Mellstrom B, Savignac M, Gomez-Villafuertes R, Naranjo JR. 2008. Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol. Rev. 88: 421-449.
25. Mezrich JD, Fechner JH, Zhang XJ, Johnson BP, Burlingham WJ, Bradfield CA. 2010. An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells. J. Immunol. 185: 3190-3198.
26. Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y. 1999. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev. 13: 20-25.
27. Mocarelli P, Marocchi A, Brambilla P, Gerthoux P, Young DS, Mantel N. 1986. Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA 256: 2687-2695.
28. Moennikes O, Loeppen S, Buchmann A, Andersson P, Ittrich C, Poellinger L, Schwarz M. 2004. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res. 64: 4707-4710.
29. Mottet C, Golshayan D. 2007. CD4(+)CD25(+)Foxp3(+) regulatory T cells: From basic research to potential therapeutic use. Swiss Med. Wkly. 137: 625-634.
30. Nebert DW, Puga A, Vasiliou V. 1993. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N. Y. Acad. Sci. 685: 624-640.
31. Needham LL, Gerthoux PM, Patterson DG, Jr., Brambilla P, Turner WE, Beretta C, Pirkle JL, Colombo L, Sampson EJ, Tramacere PL, Signorini S, Meazza L, Carreri V, Jackson RJ, Mocarelli P. 1997. Serum dioxin levels in Seveso, Italy, population in 1976. Teratog. Carcinog. Mutagen. 17: 225-240.
32. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y, Kato S. 2003. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423: 545-550.
33. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H, Takahashi S, Kouzmenko A, Nohara K, Chiba T, Fujii-Kuriyama Y, Kato S. 2007. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446: 562-566.
34. Ohtake F, Fujii-Kuriyama Y, Kato S. 2009. AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem. Pharmacol. 77: 474-484.
35. Ovando BJ, Ellison CA, Vezina CM, Olson JR. 2010. Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands. BMC Genomics 11: 583.
36. Patel CJ, Bhattacharya J, Butte AJ. 2010. An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One 5: e10746.
37. Pesatori AC, Consonni D, Bachetti S, Zocchetti C, Bonzini M, Baccarelli A, Bertazzi PA. 2003. Short- and long-term morbidity and mortality in the population exposed to dioxin after the "Seveso accident". Ind. Health 41: 127-138.
38. Pocar P, Fischer B, Klonisch T, Hombach-Klonisch S. 2005. Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 129: 379-389.
39. Poland A, Knutson JC. 1982. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22: 517-554.
40. Pollenz RS. 2002. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem. Biol. Interact. 141: 41-61.
41. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL. 2008. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71.
42. Rifkind AB. 2006. CYP1A in TCDD toxicity and in physiology - With particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Curr. Drug Metab. 38: 291-335.
43. Ryan KS, Balibar CJ, Turo KE, Walsh CT, Drennan CL. 2008. The violacein biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins. J. Biol. Chem. 283: 6467-6475.
44. Ryan KS, Drennan CL. 2009. Divergent pathways in the biosynthesis of bisindole natural products. Chem. Biol. 16: 351-364.
45. Savignac M, Mellstrom B, Naranjo JR. 2007. Calcium-dependent transcription of cytokine genes in T lymphocytes. Pflugers Arch. 454: 523-533.
46. Savouret JF, Antenos M, Quesne M, Xu J, Milgrom E, Casper RF. 2001. 7-ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor. J. Biol. Chem. 276: 3054-3059.
47. Schecter A, Birnbaum L, Ryan JJ, Constable JD. 2006. Dioxins: An overview. Environ. Res. 101: 419-428.
48. Schmidt JV, Su GHT, Reddy JK, Simon MC, Bradfield CA. 1996. Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. U.S.A. 93: 6731-6736.
49. Shanle EK, Xu W. 2010. Endocrine Disrupting Chemicals Targeting Estrogen Receptor Signaling: Identification and Mechanisms of Action. Chem. Res. Toxicol. 24: 6-19.
50. Sinal CJ, Bend JR. 1997. Aryl Hydrocarbon Receptor-Dependent Induction of Cyp1a1 by Bilirubin in Mouse Hepatoma Hepa 1c1c7 Cells. Mol. Pharmacol. 52: 590-599.
51. Sorg O, Zennegg M, Schmid P, Fedosyuk R, Valikhnovskyi R, Gaide O, Kniazevych V, Saurat JH. 2009. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites. Lancet 374: 1179-1185.
52. Stevens EA, Mezrich JD, Bradfield CA. 2009. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 127: 299-311.
53. Sutter TR, Greenlee WF. 1992. Classification of members of the Ah Gene Battery. Chemosphere 25: 223-226.
54. Swanson HI, Bradfield CA. 1993. The AH-receptor - genetics, structure and function. Pharmacogenetics 3: 213-230.
55. Swedenborg E, R++egg J, Hillenweck A, Rehnmark S, Faulds MH, Zalko D, Pongratz I, Pettersson K. 2008. 3-Methylcholanthrene Displays Dual Effects on Estrogen Receptor (ER)+> and ER+> Signaling in a Cell-Type Specific Fashion. Mol. Pharmacol. 73: 575-586.
56. Telakowski-Hopkins CA, King RG, Pickett CB. 1988. Glutathione s-transferase GA subunit gene - identification of regulatory elements required for basal level and inducible expression. Proc. Natl. Acad. Sci. U.S.A. 85: 1000-1004.
57. van den Berg M, van Birgelen A, Birnbaum L, Brouwer B, Carrier G, Dragan Y, Farland W, Feeley M, Furst P, Galli CL, Greig J, Hayashi Y, Kogevinas M, Kurokawa Y, Larsen JC, Liem AKD, Matsumura F, Mocarelli P, Moore MR, Newhook RC, Peterson RE, Poellinger L, Portier C, Rogan WJ, Schrenk D, Sweeney MH, Tohyama C, Tuomisto J, Waters J, Zeilmaker M. 2000. Consultation on assessment of the health risk of dioxins; re-evaluation of the tolerable daily intake (TDI): Executive Summary. Food Addit. Contam. 17: 223-240.
58. van Leeuwen FXR, Feeley M, Schrenk D, Larsen JC, Farland W, Younes M. 2000. Dioxins: WHO's tolerable daily intake (TDI) revisited. Chemosphere 40: 1095-1101.
59. Vanbirgelen APJM, Smit EA, Kampen IM, Groeneveld CN, Fase KM, Vanderkolk J, Poiger H, Vandenberg M, Koeman JH, Brouwer A. 1995. Subchronic Effects of 2, 3, 7, 8-Tcdd Or Pcbs on Thyroid-Hormone Metabolism - Use in Risk Assessment. Eur. J. Pharmacol. 293: 77-85.
60. Vasquez A, Atallah-Yunes N, Smith FC, You X, Chase SE, Silverstone AE, Vikstrom KL. 2003. A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovasc. Toxicol. 3: 153-163.
61. Vogel CF, Goth SR, Dong B, Pessah IN, Matsumura F. 2008. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2, 3-dioxygenase. Biochem. Biophys. Res. Commun. 375: 331-335.
62. Vogel CFA, Matsumura F. 2009. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappa B family. Biochem. Pharmacol. 77: 734-745.
63. White SS, Birnbaum LS. 2009. An Overview of the Effects of Dioxins and Dioxin-Like Compounds on Vertebrates, as Documented in Human and Ecological Epidemiology. J. Environ. Sci. Health C 27: 197-211.
64. WHO. 1998. Assessment of the Health Risk of Dioxins: Re-Evaluation of the Tolerable Daily Intake (TDI). WHO Consultation. WHO: Geneva.
65. Xie A, Walker NJ, Wang D. 2006. Dioxin (2, 3, 7, 8-tetrachlorodibenzo-p-dioxin) enhances triggered afterdepolarizations in rat ventricular myocytes. Cardiovasc. Toxicol. 6: 99-110.
66. Yeager RL, Reisman SA, Aleksunes LM, Klaassen CD. 2009. Introducing the "TCDD-inducible AhR-Nrf2 gene battery". Toxicol. Sci. 111: 238-246.